Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription


16.05.2022

1 BMC Neurol
2 J Nephrol
1 J Neurol
1 J Pediatr
6 J Pediatr Endocrinol Metab
1 Kidney Int
2 Mult Scler
1 Proc Natl Acad Sci U S A
9 Semin Hematol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. HARRIS L, Graham S, MacLachlan S, Exuzides A, et al
    A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis.
    BMC Neurol. 2022;22:172.
    PubMed         Abstract available


    J Nephrol

  2. PICCOLI GB
    The heritage of Thomas Addis: why do nephrologists still love glomerulonephritis?
    J Nephrol. 2022 May 11. pii: 10.1007/s40620-022-01343.
    PubMed        

  3. OKI R, Unagami K, Taneda S, Takagi T, et al
    Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    J Nephrol. 2022 May 6. pii: 10.1007/s40620-022-01332.
    PubMed         Abstract available


    J Neurol

  4. HONE L, Jacobs BM, Marshall C, Giovannoni G, et al
    Age-specific effects of childhood body mass index on multiple sclerosis risk.
    J Neurol. 2022 May 9. pii: 10.1007/s00415-022-11161.
    PubMed         Abstract available


    J Pediatr

  5. WHITE M, Manski-Nankervis JA
    Delayed referral and DKA in new-onset Type 1 diabetes.
    J Pediatr. 2022;244:250-254.
    PubMed        


    J Pediatr Endocrinol Metab

  6. KURBAN S, Selver Eklioglu B, Selver MB
    Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2022;35:673-679.
    PubMed         Abstract available

  7. WADE C, Burton ET, Akinseye L, Nelson G, et al
    Increased anxiety symptoms in pediatric type 1 diabetes during the acute phase of COVID-19 lockdown.
    J Pediatr Endocrinol Metab. 2022;35:627-630.
    PubMed         Abstract available

  8. KARGUPPIKAR M, Oza C, Shah N, Khadilkar V, et al
    Prevalence of nephropathy in Indian children and youth with type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2022;35:585-592.
    PubMed         Abstract available

  9. ERBAS IM, Hajikhanova A, Besci O, Acinikli KY, et al
    Initial neutrophil/lymphocyte and lymphocyte/monocyte ratios can predict future insulin need in newly diagnosed type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2022;35:593-602.
    PubMed         Abstract available

  10. TEMPARK T, Deekajorndech T, Chatproedprai S, Supornsilchai V, et al
    Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature.
    J Pediatr Endocrinol Metab. 2022;35:567-575.
    PubMed         Abstract available

  11. MOROTA K, Tadokoro H, Sawano K, Watanabe K, et al
    A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity.
    J Pediatr Endocrinol Metab. 2022;35:687-690.
    PubMed         Abstract available


    Kidney Int

  12. JAVAUGUE V, Valeri AM, Sathick IJ, Said SM, et al
    The characteristics of seronegative and seropositive non-hepatitis-associated cryoglobulinemic glomerulonephritis.
    Kidney Int. 2022 May 2. pii: S0085-2538(22)00349.
    PubMed         Abstract available


    Mult Scler

  13. MANGLANI HR, Fisher ME, Duraney EJ, Nicholas JA, et al
    A promising cognitive screener in multiple sclerosis: The NIH toolbox cognition battery concords with gold standard neuropsychological measures.
    Mult Scler. 2022 May 9:13524585221088731. doi: 10.1177/13524585221088731.
    PubMed         Abstract available

  14. CHIARAVALLOTI ND, DeLuca J, Salter A, Amato MP, et al
    The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis.
    Mult Scler. 2022 May 9:13524585221088190. doi: 10.1177/13524585221088190.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  15. KISSLER S
    Toward a precision medicine approach for autoimmunity.
    Proc Natl Acad Sci U S A. 2022;119:e2204841119.
    PubMed        


    Semin Hematol

  16. GREINACHER A, Schonborn L, Siegerist F, Steil L, et al
    Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Semin Hematol. 2022;59:97-107.
    PubMed         Abstract available

  17. GABARIN N, Arnold DM, Nazy I, Warkentin TE, et al
    Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Semin Hematol. 2022;59:89-96.
    PubMed         Abstract available

  18. WARKENTIN TE, Greinacher A
    Laboratory testing for VITT antibodies.
    Semin Hematol. 2022;59:80-88.
    PubMed         Abstract available

  19. CHEN L, Pavord S
    Clinical picture of VITT.
    Semin Hematol. 2022;59:76-79.
    PubMed         Abstract available

  20. PAI M
    Epidemiology of VITT.
    Semin Hematol. 2022;59:72-75.
    PubMed         Abstract available

  21. WARKENTIN TE
    Platelet-activating anti-PF4 disorders: An overview.
    Semin Hematol. 2022;59:59-71.
    PubMed         Abstract available

  22. WARKENTIN TE
    Vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Semin Hematol. 2022;59:57-58.
    PubMed        

  23. CARPENTER LJ, Solomons L, Grabe HJ, Pavord S, et al
    The psychiatric and psychological sequelae of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Semin Hematol. 2022;59:115-119.
    PubMed         Abstract available

  24. SCHONBORN L, Greinacher A
    Longitudinal Aspects of VITT.
    Semin Hematol. 2022;59:108-114.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: